CN102532127A - 新型p38丝裂原活化蛋白激酶抑制剂的改进的合成方法 - Google Patents
新型p38丝裂原活化蛋白激酶抑制剂的改进的合成方法 Download PDFInfo
- Publication number
- CN102532127A CN102532127A CN201110394355XA CN201110394355A CN102532127A CN 102532127 A CN102532127 A CN 102532127A CN 201110394355X A CN201110394355X A CN 201110394355XA CN 201110394355 A CN201110394355 A CN 201110394355A CN 102532127 A CN102532127 A CN 102532127A
- Authority
- CN
- China
- Prior art keywords
- novel
- compd
- mapk
- structural formula
- condensing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110394355XA CN102532127A (zh) | 2011-12-01 | 2011-12-01 | 新型p38丝裂原活化蛋白激酶抑制剂的改进的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110394355XA CN102532127A (zh) | 2011-12-01 | 2011-12-01 | 新型p38丝裂原活化蛋白激酶抑制剂的改进的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102532127A true CN102532127A (zh) | 2012-07-04 |
Family
ID=46340297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110394355XA Pending CN102532127A (zh) | 2011-12-01 | 2011-12-01 | 新型p38丝裂原活化蛋白激酶抑制剂的改进的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102532127A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010129208A1 (en) * | 2009-05-05 | 2010-11-11 | Merck Sharp & Dohme Corp. | P38 kinase inhibiting agents |
-
2011
- 2011-12-01 CN CN201110394355XA patent/CN102532127A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010129208A1 (en) * | 2009-05-05 | 2010-11-11 | Merck Sharp & Dohme Corp. | P38 kinase inhibiting agents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107176932B (zh) | 苯并恶嗪酮衍生物及其制备方法和用途 | |
CA2876268C (en) | Method for producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazol-3-yl]pyridine-2-carbonitrile | |
CN112679420A (zh) | 一种2,5-二溴吡啶的制备方法 | |
WO2019141131A1 (zh) | 溴结构域抑制剂化合物及其用途 | |
CN105566237B (zh) | 一种治疗痛风的三唑巯乙酸类化合物的制备方法 | |
CN109134434B (zh) | 喹啉或喹唑啉类化合物及其制备方法和应用 | |
KR20190034293A (ko) | 질소 함유 방향족 헤테로 고리 화합물, 이의 제조 방법, 약물 조성물 및 응용 | |
CN107973796B (zh) | 一种他达拉非异构体的制备方法 | |
CN102532127A (zh) | 新型p38丝裂原活化蛋白激酶抑制剂的改进的合成方法 | |
CN105153169B (zh) | 一种盐酸依匹斯汀的合成方法 | |
CN108586350B (zh) | 一种咪唑-2-硫酮类化合物的制备方法 | |
CN109776501A (zh) | 一种3,4-二氢喹唑啉-2(1h)-硫酮衍生物及其合成方法 | |
CN103113375B (zh) | 一类吡唑并[3,4‑d]嘧啶类化合物及其制备方法 | |
CN112250682B (zh) | 一种芳杂环修饰的萘酰亚胺衍生物及其制备方法和用途 | |
CN102260241A (zh) | 一种沙利度胺α晶型的工业化制备方法 | |
CN110003101B (zh) | 一种阿帕替尼中间体及其制备方法 | |
CN109879805B (zh) | 阿帕替尼的制备方法 | |
CN107382877A (zh) | 一种4‑氨基‑2‑甲基‑5‑(溴甲基)嘧啶氢溴酸盐的合成方法 | |
CN113620977B (zh) | 一种噻唑烷并嘧啶酮乙酸的合成方法 | |
CN114014847B (zh) | 一种含苯并噻吩嘧啶衍生物及其制备方法和在制备抗肿瘤药物中的应用 | |
CN106883185B (zh) | 一种4-氯-2-三氟甲基嘧啶的制备方法 | |
CN108658981A (zh) | 一种6-溴-4-甲氧基氢-吡唑[1,5-a]吡啶-3-甲腈的合成方法 | |
CN112457243B (zh) | 7-溴-5-甲氧基喹啉的合成方法 | |
CN116199687B (zh) | 一种β-咔啉-3位连接1,2,3-三氮唑类化合物及其制备方法、应用 | |
CN110054626B (zh) | 一种吡啶并嘧啶衍生物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI BENSUO PHARMACEUTICAL TECHNOLOGY CO., LTD Free format text: FORMER OWNER: SHANGHAI INNOCECHEM BIOPHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20120628 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Chi Junwei Inventor before: Wu Guang Inventor before: Fu Hao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WU GUANG FU HAO TO: CHI JUNWEI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120628 Address after: 200231 B-105 room 8, Lane 1305, Hua Jing Road, Shanghai, China Applicant after: Shanghai Bunso Medical Technology Co Ltd Address before: 200231 B-105, Lane 1305, Huajing Road, Shanghai, Shanghai, Xuhui District Applicant before: Shanghai Ainake Biomedicine Technology Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120704 |